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Background: The incidence of type 2 diabetes mellitus (T2DM) is increasing rapidly. This is possibly due to increasing obesity,
reduced level of activity, sedentary lifestyle, ageing population and industrialisation.
Aim: The primary objective of this study was to ascertain the level of activity using a pedometer. The secondary objectives were:
(1) to correlate the baseline level of activity with body mass index (BMI), HbA1c and blood pressure (BP), (2) to assess whether 7
000 steps a day influence HbA1c and BP over a three-month period.
Method: A total of 110 patients were screened; 95 patients (n = 95) completed the study. At the first visit HbA1c, BMI and BP were
measured. At the end of the first month baseline physical activity was recorded using pedometers. Patients were divided into two
groups: active (n = 50) and control (n = 45). Patients in the active group were asked to walk a minimum of 7 000 steps/day. The
control group were asked to continue their usual activity. These patients were followed up monthly over a period of three
months. At each visit BMI, BP and step counts were recorded. HbA1c was measured only at the first and last visit.
Result: Activity levels increased significantly in the active group throughout the study. Mean step count for the control group at
baseline was 2 923.1 ± 1 136.9, which increased to 3 431.2 ± 1 251.7 by the end of the study. Mean step count for the active group
at baseline was 4 609.9 ± 1 702.1, which increased to 7 244.8 ± 1 419.4 by the end of the study. The difference between control and
active group was statistically significant (p < 0.001). Systolic and diastolic BP decreased significantly in both groups (p = 0.017) for
systolic BP and (p = 0.002) for diastolic BP but no interaction was found between the groups as systolic and diastolic BP decreased
at the same rate over time in both groups. HbA1c decreased by 1.04% in the active group; this difference was statistically highly
significant (p < 0.001).
Conclusion: Increase in activity levels decreases HbA1c by 1.04 percentage point over three months in T2DM (p < 0.001), which is
statistically significant.
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Introduction
The incidence of type 2 diabetes mellitus (T2DM) is increasing
rapidly. This is possibly due to increasing obesity, reduced level of
activity, sedentary lifestyle, ageingpopulation and industrialisation.1
In the USA in 2010, the prevalence of diabetes was estimated to
be 0.2% in individuals aged less than 20 years and 11.3% in indi-
viduals older than 20 years.1 Diabetes increases with age. It is the
fifth leading cause of death worldwide. In 2010 about four
million people died as a result of complications due to diabetes.1
There are three and half million South Africans with diabetes
(approximately 6% of the population) and many remain undiag-
nosed.2 Worldwide, more than 400 million people have diabetes.
The International Diabetes Federation (IDF) has predicted that
this figure will increase to 552 million by 2030.2 It is expected
that the greatest increase will be on the African continent and
it is predicted that by 2030 the prevalence of diabetes in
Africa will almost have doubled. Besides the important causative
factors mentioned above, there is a cultural belief among most
African communities that weight gain is a reflection of social
achievement, well-being and honour.2
T2DM occurs almost exclusively in the adult population and its
main feature is insulin resistance, manifested as hyperinsulinemia
and hyperglycaemia. It is strongly associated with family history,
obesity and physical inactivity, which accounts for 90% of all dia-
betes.3 The typical patient with T2DM is sedentary, overweight
and middle-aged or older.3,4 In type 1 diabetes (T1DM) there is
autoimmune destruction of the pancreas leading to a failure to
secrete insulin.3
Regular physical activity (PA) is necessary for the prevention and
management of T2DM and is associated with a lower incidence
of all-cause and cardiovascular disease mortality in patients with
diabetes.5 The Diabetes Prevention Program (DPP) found that a
minimum of 150 minutes/week of moderate-intensity PA, such
as brisk walking, was more efficient than metformin or
placebo in the prevention of T2DM in pre-diabetics.6 Similarly,
Heimrich et al. described an inverse relationship between
energy consumption in leisure-time PA and the development
of T2DM in former college students.7
The advantages of regular PA in diabetes are: (1) better glycae-
mic control, (2) weight reduction and (3) improved insulin sensi-
tivity.8,9 The latter is integral to the prevention of cardiovascular
complications, as impaired insulin activity can lead to elevated
triglycerides, reduced high-density lipoprotein cholesterol,
increased secretion of very low-density lipoprotein cholesterol,
and hypertension.10
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The United Kingdom Prospective Diabetes Study (UKPDS)
showed that intensive glucose control with metformin
decreased glycated haemoglobin (HbA1c) by 0.6%. This
reduction was associated with a 32% decreased risk of dia-
betes-associated complications and 42% decrease in the mor-
tality rate.11
There is no doubt that PA is beneficial to patients with diabetes.
However, the minimum degree and frequency of activity
required to achieve favourable outcomes has not been fully
explained. While the Centres for Disease Control and Prevention
(CDC) and the American College of Sports Medicine (ACSM) have
suggested a minimum of 30 minutes of moderate-intensity PA
on most days of the week,12 Tudor-Locke et al. believe that
walking 10 000 steps/day is effective.13
Even though the health benefits of moderate PA in diabetes
have been established, the compliance with exercise is sadly
low. Pedometers may be used as a motivational tool to encou-
rage people with T2DM to increase their PA.
The primary objective of this study was to ascertain the level of
activity using a pedometer. The secondary objectives were: (1) to
correlate the baseline level of activity with body mass index
(BMI), HbA1c and blood pressure (BP), (2) to assess whether 7
000 steps a day influence HbA1c and BP over a three-month
period.
Method
A prospective observational study was conducted at the diabetic
clinic at Chris Hani Baragwanath Academic Hospital from August
2015 to January 2016. The study was aimed at African male and
female diabetic patients between the ages of 18 and 65 years
attending the diabetic clinic. This study was approved by Wits
Human Research Ethics committee. Inclusion criteria:
(1) T2DM; 18–65 years old;
(2) Signed consent;
(3) Patient having HbA1c measured as standard care in the
clinic.
Patients with T1DM and patients having any disability that may
affect walking such as amputation of a leg were excluded from
the study. A sample size of 75 was obtained using mean change
and standard deviation in HbA1c for the intervention and
control groups at the 5% significance level and 80% power.14
However, the sample size was increased to 110 to account for
the maximum number of variables that may be included in
regression analysis. A sample size of 15 is required for each vari-
able added to the model. Patients were screened randomly from
the diabetic clinic over a period of two months from July 2015 to
September 2015 and were further followed up for a total period
of four months. Ninety-five patients completed the study. Health
variables such as bodyweight in kilograms (kg) and height in
metres were measured with patients wearing light clothing
and no shoes. BP was measured in a sitting position with a
Welch Allyn monitor (Welch Allyn Inc, Skaneateles Falls, NY,
USA). HbA1c was measured on a DCA Vantage analyser
(Siemens, Erlangen, Germany).
At the first visit, patients were informed about the study and
were given an information sheet containing a brief description
of the study. All patients enrolled in the study were given a
multi-function pedometer and a step-count log.
Patients were advised to wear the pedometer throughout the
day with an exception during sleeping and bathing, and the
number of steps were recorded every evening before sleeping.
Baseline activity was ascertained at the end of the first month,
after which the participants were divided into two groups,
active and control.
Participants with a higher step count in the first month and
those willing to increase their steps to 7 000 per day were
included in the active group; the rest were in the control
group. Participants in the active group were given a plan to
increase their daily physical activity by starting regular
morning or evening walking, to participate in sporting activity,
to join an exercise club or even to join the gym if possible.
The control group were asked to continue their usual activity
and to log their steps. Both groups were followed up for the
next three months. At each visit the patient’s BP and weight
were recorded, and a new step log issued. HbA1c was only
measured at the first visit and last visit.
Statistical methods
IBM SPSS® version 23 (IBM Corp, Armonk, NY, USA) was used to
analyse the data. A p-value < 0.05 was considered as statistically
significant. Categorical variables were compared between the
two groups using Pearson’s chi-square test. Independent
samples t-tests were used to compare normal continuous vari-
ables between the two groups. Pearson’s correlation coefficient
was used to assess the strength of relationships between con-
tinuous variables. Repeated measures ANOVA testing was used
to assess changes over time within and between groups. A
time x group interaction that was statistically significant indi-
cated a treatment effect. Profile plots were used to show the




Ninety-five participants were analysed. Their age and gender by
group are given in Table 1 below. There was no difference
between the groups in term of age and gender. Mean age for
the control group was 54.1 years compared with 55.2 years for
the active group.
The primary objective was to ascertain the level of activity using
a pedometer. There was a significant difference in step counts at
baseline between the two groups. The difference in step counts
between males and females, and between different age groups,





Gender Male n 14 17 0.764
n, % 31.1% 34.0%
Female n 31 33
n, % 68.9% 66.0%
Age n 45 50
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at month 3 there was a significant difference between male and
female steps (p = 0.045) (Tables 2 and 3).
Table 4 shows the mean number of steps measured at each time
point using a pedometer by study arms. Mean step count for the
control group was 2 923.1 ± 1 136.9 steps compared with 4
609.9 ± 1 702.1 steps for the active group at baseline which
increased to 3 431.2 ± 1 251.7 steps and 7 244.8 ± 1 419.4
steps respectively at the end of the study. The difference was
highly statistically significant at all time points (p < 0.001), with
the active group taking significantly more steps than the
control group.
The secondary objective was to correlate the baseline level of
activity with BMI, HbA1c and BP.
There was no significant difference between the active and
control groups in terms of baseline outcomes. Mean BMI for
the control group was 33.93 ± 5.84 kg/m2 compared with
32.60 ± 6.92 kg/m2 for the active group (p = 0.317). Similarly
mean HbA1c for the control group was 9.85 ± 2.38% compared
with 9.86 ± 2.40% for the active group (p = 0.989) (Table 5).
There was also no correlation between average number of steps
at baseline and BMI, systolic BP (SBP), diastolic BP (DBP) or
HbA1c (Table 6).
The other secondary objective was to assess whether 7 000 steps
a day influence HbA1c and BP over a three-month period.
HbA1c
1. To assess whether being in the active group versus the
control group influences HbA1c over a three-month period
There was a highly significant interaction between time and
treatment group (p < 0.001), indicating that the two study
arms did not behave in the same way over time for HbA1c.







Male Female Male Female
Month 1 Mean 3 357.8 2 726.8 0.085 4 681.8 4 572.8 0.833
Standard deviation 1 001.9 1 154.5 1 530.4 1 805.8
Month 2 Mean 3 551.6 3 067.5 0.139 6 058.7 6 598.9 0.134
Standard deviation 876.3 1 044.3 1 131.5 1 211.7
Month 3 Mean 3 721.9 3 013.8 0.045 7 121.3 6 859.5 0.452
Standard deviation 1 159.3 1 023.5 1 347.6 1 046.9
Month 4 Mean 3 781.4 3 273.0 0.211 7 134.7 7 301.5 0.698
Standard deviation 949.9 1 350.4 1 273.6 1 504.7






Age group Age group
≤ 50 51–60 > 60 ≤ 50 51–60 > 60
Month 1 Mean 3 163.2 2 762.5 2 863.8 0.599 5 170.6 4 690.6 3 799.9 0.146
Standard deviation 1 031.7 1 197.1 1 215.1 1 567.1 1 884.1 1 071.9
Month 2 Mean 3 294.9 3 042.8 3 385.2 0.630 6 604.7 6 466.9 6 081.8 0.560
Standard deviation 811.8 1 004.5 1 264.9 675.5 1 510.0 686.6
Month 3 Mean 3 108.1 3 162.7 3 498.6 0.630 7 256.3 6 945.6 6 619.7 0.424
Standard deviation 852.8 1 170.1 1 318.0 805.5 1 189.4 1 365.9
Month 4 Mean 3 411.4 3 317.6 3 626.1 0.809 7 481.0 7 005.4 7 574.5 0.437
Standard deviation 1 371.8 1 247.5 1 184.6 1 074.1 1 119.4 2 236.8




n Mean Standard deviation n Mean Standard deviation
Month 1 45 2 923.1 1 136.9 50 4 609.9 1 702.1
Month 2 45 3 218.1 1 010.8 50 6 415.2 1 201.5
Month 3 45 3 234.1 1 105.1 50 6 948.5 1 150.9
Month 4 45 3 431.2 1 251.7 50 7 244.8 1 419.4
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Figure 1 shows that the active arm reduced their HbA1c over the
two time-points while the control arm increased.
The change in HbA1c and BMI over the three-month period was
calculated and compared between the treatment groups. The
HbA1c change on average was 0.86% increase in the control
arm and 1.04% decrease in the active arm. This was highly a sig-
nificantly different between the arms (p < 0.001) The BMI change
was positive for both groups and was not different between the
arms (Table 7).
Blood pressure
2.To assess whether being in the active group versus the
control group influences BP over a three-month period
When comparing SBP between the two arms, there was no inter-
action between time and study arm for SBP (p = 0.866), meaning
that the SBP changed at the same rate over time in both groups.
There was a significant time effect (p = 0.017), meaning that
there was a general decrease in SBP over time. Figure 2 shows
this decrease in both groups over time.
There was no interaction between time and study arm for DBP (p
= 0.331), meaning that the DBP changed at the same rate over
time in both groups. There was a significant time effect (p =
0.002), meaning that there was a general decrease in DBP over
time. Figure 3 shows this decrease over time in the two groups.
In both groups there was a weak negative correlation between
change in steps and change in HbA1c, meaning that as the
steps increased the HbA1c decreased (as in the active group)
or that as the steps decreased, HbA1c increased (as in the
control group).
However, the change in steps in the control group over the entire
study period was much lower than the change in steps in the
active arm (mean = 508 in control and 2 634 in the active arm).
Similarly, the change in HbA1c was positive (i.e. an increase) in
the control arm (mean = 0.8622) and negative in the active arm
(i.e. a decrease) (mean =−1.042). Figure 4 explains this phenom-
enon—the control arm (white circles) weremainly above the hori-
zontal line meaning they increased in HbA1c, and most of the
white circles are in the right-hand box meaning they increased
in steps. The few in the left-hand block are influencing the
relationship (correlation) to be negative, i.e. they increased
HbA1c while decreasing steps. In contrast, the active group are
mainly in the lower right-hand quadrant, which shows that they
decreased HbA1c while increasing steps.
Discussion
There was a significant difference in step counts at baseline
between the two groups. Although most of the patients in the
Table 6: Correlation of baseline activity with BMI, HbA1c and BP
Baseline Average steps 1
BMI (kg/m2) Pearson correlation 0.014
Sig. (2-tailed) 0.891
n 95
SBP (mmHg) Pearson correlation 0.106
Sig. (2-tailed) 0.307
n 95
DBP (mmHg) Pearson correlation 0.074
Sig. (2-tailed) 0.476
n 95
HbA1c (%) Pearson correlation –0.103
Sig. (2-tailed) 0.322
n 95
Table 5: Baseline BMI, HbA1c and blood pressure
Group statistics
p-valueBaseline Study arms n Mean Std deviation Std error mean
Weight (kg) Control 45 89.076 16.0405 2.3912 0.264
Active 50 85.248 17.0379 2.4095
BMI (kg/m2) Control 45 33.934 5.8443 0.8712 0.317
Active 50 32.603 6.9276 0.9797
HbA1c % Control 45 9.8573 2.38969 0.35623 0.989
Active 50 9.8640 2.40508 0.34013
SBP (mmHg) Control 45 147.16 19.454 2.900 0.694
Active 50 148.90 23.211 3.283
DBP (mmHg) Control 45 85.58 10.319 1.538 0.906
Active 50 85.84 11.164 1.579
Figure 1: Estimated marginal means of HbA1c over a four-month period
in the control and active arms.
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active group were more active at baseline but their physical
activity increased significantly throughout the study, ped-
ometer-based motivation had a significant impact on step
counts in the active group (Table 4).
There was also no significant difference in BMI, HbA1c and BP
between the two groups at baseline (Table 5). We did not find
any correlation between average number of steps at baseline
and BMI, SBP, DBP or HbA1c (Table 6).
There was a significant decrease in SBP and DBP in both
groups during the course of study, but no interaction was
found between the groups as SBP and DBP decreased at
the same rate in both groups over this time period. The
active group had a greater trend in a decrease in DBP as
compared with the control, but this difference was not stat-
istically significant, as depicted in Figures 2 and 3
respectively.
The HbA1c changed significantly over the course of three
months in the active group. On average, the HbA1c increased
by 0.86 percentage points in the control group and decreased
by 1.04 percentage points in the active group, which was
highly significant (p < 0.001) (Table 7). The increase in physical
activity to 7 000 steps per day had a significant effect on
HbA1c. This decrease in HbA1c is higher than the decrease
shown in the metformin arm of the UKPDS, a decrease of
HbA1c by 0.6 percentage points.11 The UKPDS was associated
with a 32% decrease risk of diabetes-associated complications
and a 42% decrease in mortality.11
Our study differs from a pedometer-based behavioural modifi-
cation programme in T2DM patients, where 92 patients with
T2DM patients that were enrolled from Ghent University Hospi-
tal showed no noticeable immediate or short-term disparities in
Table 7: Change in HbA1c and BMI over three-month period
Group statistics
pvalueChange Study arms n Mean Std deviation Std error mean
HbA1c (%) Control 45 0.8622 1.12337 0.16746 < 0.001
Active 50 −1.0420 1.27633 0.18050
BMI (kg/m2) Control 45 .2170 0.90158 0.13440 0.611
Active 50 0.1209 0.93103 0.13167
Figure 2: Estimated marginal means of SBP between the two arms.
Figure 3: Estimated marginal means of DBP between the two arms.
Figure 4: Correlation between change in steps and change in HbA1c.
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health outcomes between the control and intervention group.
But the study highlighted an important threshold of ≥ 4 000
steps/days to influence HbA1c.14
Our results confirm that community or clinic-based PA pro-
grammes may be employed as a useful strategy for manage-
ment of T2DM. Our study’s results are more favourable than a
meta-analysis by Plotnikoff et al., where community-based PA
programmes were associated with a reduction in HbA1c of
0.32% (p = 0.06).15 Their research was organised in various
countries that included various ethnic and cultural groups.
Most of the research (16/22) in this meta-analysis comprised ran-
domised control trials. These studies across various ethnic and
cultural groups demonstrated that community- based pro-
grammes using PA as a main component can effectively
decrease HbA1c level, reduce weight and increase PA levels. If
our study was conducted over a longer duration, we might
have shown a decrease in weight and/or BMI. This study is
also limited by small numbers and lack of a prescribed plan to
achieve a target of 7 000 steps/day.
Conclusion
This study demonstrates that even in sedentary diabetic popu-
lations a passive, inexpensive tool such as a pedometer may
positively influence PA to significantly achieve a meaningful
reduction in HbA1c of 1.04% (p < 0.001) without much effort
or motivation on the part of healthcare providers. This could
translate to other tools that could measure step counts, e.g.
cell phones or watches.
We suggest that a study like this could be conducted over a
longer period of time to gauge any positive benefit on metabolic
parameters such as BP and weight, and to see if the PA and
change in metabolic parameters are sustainable.
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